ACUTE CORONARY SYNDROME-HYPERLIPIDEMIA

SUMMARY

1. The 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults states that all patients with CAD should receive a high-intensity statin, regardless of lipid levels.

2. High-intensity statin: lowers LDL by at least 50% on average. Includes: atorvastatin 40-80 mg and rosuvastatin 20-40 mg.

3. Statins enhance plaque stabilization and can independently improve long-term prognosis.

Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].